Loading…
Comparison of left ventricular subclinical systolic dysfunction between hemodialysis patients and renal transplant recipients using real time three‐dimensional echocardiography
Aims The relationship between chronic kidney disease and development of heart failure is a well‐known clinical entity. Systolic dyssynchrony index (SDI_16) is a new diagnostic tool for detection of subclinical left ventricular (LV) systolic dysfunction by using three‐dimensional echocardiography (3D...
Saved in:
Published in: | Echocardiography (Mount Kisco, N.Y.) N.Y.), 2022-05, Vol.39 (5), p.708-716 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims
The relationship between chronic kidney disease and development of heart failure is a well‐known clinical entity. Systolic dyssynchrony index (SDI_16) is a new diagnostic tool for detection of subclinical left ventricular (LV) systolic dysfunction by using three‐dimensional echocardiography (3DE). We aimed to investigate this parameter in patients with end‐stage renal disease who were receiving hemodialysis and patients with renal transplant compared to healthy control subjects.
Material and Methods
Forty‐five hemodialysis patients, 45 patients with renal transplant and 45 age‐sex matched healthy control subjects included in the study. All participants were evaluated with 3DE in the interdialytic phase for measurement of LV volumes, ejection fraction and SDI_16 parameter.
Results
Both LV diastolic and systolic volumes were significantly higher in hemodialysis group compared to renal transplant group and healthy controls, but this finding did not translate to a statistically significant difference for LVEF measurements between groups (58.71 ± 3.53 vs. 57.17 ± 2.97 vs. 59.23 ± 3.26, p = .16 for renal transplant and hemodialysis and healthy control groups, respectively). Mean value of SDI_16 parameters was significantly higher in hemodialysis group compared to renal transplant group (7.93 ± 2.50 vs. 3.72 ± 1.71, p < .001) and healthy controls (7.93 ± 2.50 vs. 3.00 ± .99, p < .001); whereas, it was similar between renal transplant group and control subjects (3.72 ± 1.71 vs. 3.00 ± .99, p = .10).
Conclusion
SDI_16 was significantly higher in hemodialysis patients compared to patients with renal transplant and healthy controls. |
---|---|
ISSN: | 0742-2822 1540-8175 |
DOI: | 10.1111/echo.15352 |